AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock ...

The findings from the study were presented at the AACR ... Accordingly, we expect the market sentiment surrounding the EXAS stock to remain positive surrounding this development.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The value of charities’ investable assets has stabilised and, in some cases, improved over the last 12 months, research from ...

One of the strategies financial experts recommend is dollar-cost averaging, where investors invest on an ongoing basis, ...

Also Read: Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap ... Price Action: AbbVie stock is down 10.6% at $178.32, while Bristol Myers Squibb stock is up ...

Shares in biotech firm Moderna (NASDAQ: MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to ...

Technically, the index on a daily scale has formed a Doji candle near its 200-Days exponential moving average (DEMA) support ...

Can fund managers pick stocks that provide greater investor returns, or is successful active management a myth? Is an index ...

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...